ProteoNic unveils 2G UNic transposon platform for enhanced biologics production
Dutch biotechnology company ProteoNic has announced the commercial launch of its 2G UNic transposon platform, combining established vector technology with proprietary transposon systems to improve cell line productivity and reduce development timelines for complex biologics manufacturing.













